Evidence map›Paper›PMID 37900160›Full record

ArticleFrontiers in pharmacology2023

Evidence for the existence of facilitatory interactions between the dopamine D2 receptor and the oxytocin receptor in the amygdala of the rat. Relevance for anxiolytic actions.

Juan Carlos Hernández-Mondragón, Dexter A Hernández-Hernández, Minerva Crespo-Ramírez, Oscar Prospero-García, Luisa Rocha-Arrieta, Kjell Fuxe, Dasiel O Borroto-Escuela, Miguel Perez de la Mora

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Juan Carlos Hernández-MondragónInstituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Dexter A Hernández-HernándezInstituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Minerva Crespo-RamírezInstituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Oscar Prospero-GarcíaLaboratorio de Cannabinoides, Departamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.
Luisa Rocha-ArrietaDepartment of Pharmacobiology, Centro de Investigación y Estudios Avanzados (CINVESTAV, Sede Sur), Mexico City, Mexico.
Kjell FuxeDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Dasiel O Borroto-EscuelaDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Miguel Perez de la MoraInstituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Universidad Nacional Autónoma de México · MXKarolinska Institutet · SECenter for Research and Advanced Studies of the National Polytechnic Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

amygdalaanxietydopamine D2 receptorG protein-coupled receptorsheteroreceptor complexesoligomerizationoxytocin receptor

Identifiers

PMID37900160
PMCPMC10603234
OpenAlexW4387568593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.